Thirty-five years’ experience with the whole-cell pertussis vaccine in France: vaccine strains analysis and immunogenicity

This publication has 11 references indexed in Scilit:

• Polymorphism of Bordetella pertussis Isolates Circulating for the Last 10 Years in France, Where a Single Effective Whole-Cell Vaccine Has Been Used for More than 30 Years
  Journal of Clinical Microbiology, 2001
• Reemergence of Pertussis in the Highly Vaccinated Population of The Netherlands: Observations on Surveillance Data
  Emerging Infectious Diseases, 2000
• Epidemiological Typing of Bordetella pertussis Isolates: Recommendations for a Standard Methodology
  European Journal of Clinical Microbiology & Infectious Diseases, 2000
• Intranasal murine model of Bordetella pertussis infection: II. Sequence variation and protection induced by a tricomponent acellular vaccine1Financial support for the present study was provided by the Institut Pasteur Fondation and SmithKline Beecham Biologicals. All animal studies were conducted in accordance with the French and Belgian national legislative guidelines for animal experimentation.1
  Vaccine, 1999
• Epidemiology of pertussis in French hospitals in 1993 and 1994: thirty years after a routine use of vaccination
  The Pediatric Infectious Disease Journal, 1998
• A randomized double-blind trial comparing a two-component acellular to a whole-cell pertussis vaccine in Senegal
  Vaccine, 1997
• Pertussis: current concepts of pathogenesis and prevention
  The Pediatric Infectious Disease Journal, 1997
• New Aspects of Pertussis in France, 26 Years After Generalized Pertussis Vaccination
  Biologicals, 1993
• Determination of circulating antibodies directed to pertussis toxin and of agglutinogens in children vaccinated with either the whole cell or component pertussis vaccine in France, Japan and Senegal
  Vaccine, 1991
• The return of pertussis
  The Pediatric Infectious Disease Journal, 1987